RBC
TMO icon

Romano Brothers & Co’s Thermo Fisher Scientific TMO Stock Holding History

Romano Brothers & Co’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$725K Buy
1,447
+10
+0.7% +$4.8K 0.07% 200
2026
Q1 		$706K Sell
1,437
-40
-3% -$21.7K 0.08% 195
2025
Q4 		$856K Sell
1,477
-65
-4% -$36.8K 0.1% 180
2025
Q3 		$748K Hold
1,542
– – 0.09% 194
2025
Q2 		$625K Buy
1,542
+165
+12% +$69K 0.08% 201
2025
Q1 		$685K Buy
1,377
+447
+48% +$242K 0.09% 186
2024
Q4 		$484K Buy
930
+15
+2% +$8.25K 0.06% 212
2024
Q3 		$566K Sell
915
-7
-0.8% -$4.14K 0.07% 202
2024
Q2 		$510K Buy
922
+35
+4% +$20.1K 0.07% 208
2024
Q1 		$516K Hold
887
– – 0.07% 204
2023
Q4 		$471K Sell
887
-71
-7% -$34.4K 0.07% 201
2023
Q3 		$485K Hold
958
– – 0.08% 203
2023
Q2 		$500K Buy
958
+17
+2% +$9.17K 0.07% 207
2023
Q1 		$542K Buy
941
+35
+4% +$19.7K 0.08% 198
2022
Q4 		$499K Buy
906
+27
+3% +$14.3K 0.08% 202
2022
Q3 		$446K Buy
+879
New +$492K 0.07% 209

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Romano Brothers & Co's TMO Position: Q2 2026 in Review

Romano Brothers & Co increased its Thermo Fisher Scientific (TMO) stake by 0.7% in Q2 2026, buying an estimated $4.8K and bringing the position to 1,447 shares worth $725K. The position accounts for 0.07% of the portfolio, ranked #200.

Romano Brothers & Co first reported a position in TMO in Q3 2022 and has held it in 16 quarters since. The position peaked at $856K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Romano Brothers & Co held 1,447 shares of Thermo Fisher Scientific worth $725K as of Q2 2026.
  • Romano Brothers & Co bought 10 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.8K.
  • Thermo Fisher Scientific made up 0.07% of Romano Brothers & Co's portfolio in Q2 2026, its #200 holding.
  • Romano Brothers & Co first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 16 quarters since.
  • Romano Brothers & Co's Thermo Fisher Scientific position peaked at $856K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.